How has been the historical performance of Alkosign?

Answer:The historical performance of Alkosign shows significant growth in key financial metrics from March 2024 to March 2025.

Breakdown:
Alkosign's net sales increased from 35.69 Cr in March 2024 to 51.53 Cr in March 2025, reflecting a strong growth trajectory. Total operating income followed suit, rising to 51.53 Cr from 35.69 Cr, while total expenditure also increased to 43.72 Cr from 31.19 Cr. The operating profit (PBDIT) excluding other income improved to 7.81 Cr from 4.50 Cr, leading to an overall operating profit of 8.13 Cr, up from 4.78 Cr. Profit before tax surged to 4.62 Cr from 0.67 Cr, and profit after tax rose significantly to 3.77 Cr from 0.78 Cr. The earnings per share (EPS) also saw a notable increase, reaching 3.49 from 1.08. On the balance sheet, shareholder's funds grew to 32.99 Cr from 29.22 Cr, while total liabilities increased slightly to 50.92 Cr from 49.70 Cr. The total debt decreased to 12.55 Cr from 13.84 Cr, indicating improved financial health. Cash flow from operating activities remained at 0.00 Cr, but net cash inflow improved to 5.00 Cr from a previous outflow. Overall, Alkosign demonstrated robust growth in sales, profits, and shareholder equity, positioning itself favorably in the market.